SEC 13F Intelligence

Checkpoint Capital L.P. / AXSM

Checkpoint Capital L.P.’s Axsome Therapeutics Inc. Position

Does Checkpoint Capital L.P. own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 174.8K shares worth $15M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$15M
Q4 2024
Shares
174.8K
% of Portfolio
+7.53%
Quarters Held
5
position exited

Position History AXSM

Reported value by quarter
Q4 ’23: $12MQ4 ’23Q1 ’24: $11MQ1 ’24Q2 ’24: $23MQ2 ’24Q3 ’24: $19MQ3 ’24Q4 ’24: $15MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024174.8K$15M+7.53%
Q3 2024209.6K$19M+9.35%
Q2 2024290.8K$23M+14.11%
Q1 2024132.4K$11M+7.06%
Q4 2023155.3K$12M+7.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of AXSM.